An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis.

Philipp RiffelJuliana SchwaabChristopher LutzNicole NaumannGeorgia MetzgerothAlice FabariusStefan O SchoenbergWolf-Karsten HofmannPeter ValentAndreas ReiterMohamad Jawhar

Published in: Journal of cancer research and clinical oncology (2020)

Osteoporosis is a common feature in ISM but not in AdvSM. An increased BMD is frequently present in AdvSM but not in ISM and is associated with more advanced disease and inferior outcome.

Keyphrases

bone mineral density
prognostic factors
postmenopausal women
body composition
machine learning
deep learning
emergency department